Radiographic tumor regression as a predictor for pathologic response after neoadjuvant therapy for non–small cell lung cancer

作者
Justin M. Bader,Theresa Ermer,William De Santis,Henna Ragoowansi,Ryan J. Kramer,Emily June Zolfaghari,Elizabeth E. Tremblay,Benjamin J. Resio,Daniel J. Boffa,Justin David Blasberg,Anna S Bader,Sanja Dacic,Gavitt Alida Woodard
出处
期刊:JTCVS open [Elsevier BV]
卷期号:32: 101831-101831 被引量:1
标识
DOI:10.1016/j.xjon.2026.101831
摘要

Objective: This study evaluated correlations between radiographic tumor response and pathologic response to neoadjuvant therapy in non-small cell lung cancer. Methods: All patients with stage IB-IV non-small cell lung cancer treated with neoadjuvant therapy and surgery between 2015 and 2025 in a large health system were included. Demographics, pathologic, treatment, and radiographic data were collected. Per Response Evaluation Criteria In Solid Tumors 1.1, patients were stratified by radiographic tumor size decrease ≥30% from baseline (objective radiographic response, ORR) versus decrease <30% (radiographic stable disease). Major pathologic response and pathologic complete response (pCR) were determined by pathologist review. Results: = .0025, respectively). Among patients with ORR, 43% (10/23) did not have major pathologic response, reflecting persistent viable tumor in many patients with ORR. Programmed cell death ligand 1 status, tumor histology, and specific neoadjuvant treatments were not associated with radiographic or pathologic response. Conclusions: Radiographic reduction in tumor size and decreased PET SUVmax were significantly associated with pCR after neoadjuvant therapy. Although most patients with ORR attained pCR, viable tumor persisted in some patients with ORR and, conversely, there were some patients who had complete or major pathologic response despite radiographic stability after neoadjuvant therapy. Our findings demonstrate that radiographic response can reflect pathologic response, and with further validation, may provide an objective marker for long-term outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
蹦沙卡拉卡完成签到,获得积分10
1秒前
1秒前
2秒前
2021完成签到 ,获得积分10
2秒前
jiang完成签到,获得积分10
2秒前
CipherSage的应助被Evelyn采纳,获得10
3秒前
自由可兰发布了新的文献求助10
3秒前
tt发布了新的文献求助10
3秒前
亚尔驳回了田様的应助
4秒前
xudaniel发布了新的文献求助10
4秒前
荷呵呵完成签到,获得积分10
4秒前
4秒前
TT123发布了新的文献求助10
4秒前
chengzinie发布了新的文献求助10
4秒前
4秒前
张晓发布了新的文献求助10
4秒前
西柚宝宝完成签到,获得积分10
4秒前
小贾完成签到,获得积分10
5秒前
5秒前
wy.he的应助被鲤鱼采纳,获得10
6秒前
非海星关注了科研通微信公众号
6秒前
6秒前
smh发布了新的文献求助10
7秒前
CipherSage的应助被heng采纳,获得10
7秒前
7秒前
顾鹏飞发布了新的文献求助10
7秒前
阿果发布了新的文献求助10
7秒前
jiang发布了新的文献求助10
7秒前
小萝卜头完成签到,获得积分10
7秒前
jluzz完成签到,获得积分0
7秒前
小在完成签到,获得积分10
7秒前
cqnuly完成签到,获得积分10
7秒前
Hysen_L完成签到,获得积分10
8秒前
扑灯的飞蛾完成签到,获得积分10
8秒前
56455完成签到,获得积分10
8秒前
9秒前
9秒前
9秒前
福崽发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707